Morning ALL, A few thoughts for reflection:
Post# of 30028
Posted On: 12/30/2014 8:31:15 AM
Morning ALL,
A few thoughts for reflection:
1. You have a CEO who has been transparent from day ONE - communicates regularly with investors through Twitter, Blogs, regular PRs and respond to "some" people's emails on a regular basis. How awesome is that, even though some people have used that candid information to manipulate the stock.
2. Can anyone here name another biotech that is as young as Amarantus and has such a robust pipeline - ANYONE?
a. LymPro that is about to revolutionize detecting Alzheimers at an early stage making treatment a better possibility. Pharma is all over it due to price, time to diagnose and effectiveness. Foolish to think otherwise.
b. MANF is simply revolutionary. We have the IP protection to a protein that protects cells, helps sickly cells get better and promotes proliferation of cells ( birth of new cells). Are you kidding me? Think about how many researchers, institutions, scientists, etc. around the world are doing research using MANF. How much work has AMARANTUS had to do on MANF - very little. Everyone else is doing it for us.
c. PhenoGuard is going to continue to produce brothers and sisters like MANF. I don't think JC would be wasting his time if he felt otherwise.
d. ESS...What can anyone say about this little gem GC just added to our War Chest? Next time anyone here comes across a "burn" victim, ask them how they would feel about what ESS could do for them. REVOLUTIONARY!
e. Eltoprazine does what?
f. NuroPro...
g. other additions...um...
h.P16! Let's not forget this little Gem found by our little friend from Leipzig. As GC stated - "BRILLIANT" work! I'll take his words to mean great things.
"What was most intriguing about this article for me was the author’s discussion about the availability of Alzheimer’s blood tests being described in the future tense. We believe the timing of this article is ideal, as our emerging diagnostics division, Amarantus Diagnostics, is ready to have a major impact in the field of biomarkers to diagnose Alzheimer’s disease, and potentially monitor drug response."
P.S. Let the "MAN" and his TEAM do their job. Anyone that knows anything about BUSINESS knows one thing - it has so many moving parts - some in one's control others not - that MANAGEMENT needs to constantly be "tweaking" its roadmap. Some here know how invested I am (over my head) and I have never felt as confident about Amarantus as I do currently. It is easy to be disappointed and lose patience considering we sit at .08. However, in the "blink of an eye" we will be in the dollars without a RS IMO. Have FAITH or alleviate your mind and just sell. Two words constantly resonate whenever I think of AMARANTUS - "Golden Goose!"
Manolo
A few thoughts for reflection:
1. You have a CEO who has been transparent from day ONE - communicates regularly with investors through Twitter, Blogs, regular PRs and respond to "some" people's emails on a regular basis. How awesome is that, even though some people have used that candid information to manipulate the stock.
2. Can anyone here name another biotech that is as young as Amarantus and has such a robust pipeline - ANYONE?
a. LymPro that is about to revolutionize detecting Alzheimers at an early stage making treatment a better possibility. Pharma is all over it due to price, time to diagnose and effectiveness. Foolish to think otherwise.
b. MANF is simply revolutionary. We have the IP protection to a protein that protects cells, helps sickly cells get better and promotes proliferation of cells ( birth of new cells). Are you kidding me? Think about how many researchers, institutions, scientists, etc. around the world are doing research using MANF. How much work has AMARANTUS had to do on MANF - very little. Everyone else is doing it for us.
c. PhenoGuard is going to continue to produce brothers and sisters like MANF. I don't think JC would be wasting his time if he felt otherwise.
d. ESS...What can anyone say about this little gem GC just added to our War Chest? Next time anyone here comes across a "burn" victim, ask them how they would feel about what ESS could do for them. REVOLUTIONARY!
e. Eltoprazine does what?
f. NuroPro...
g. other additions...um...
h.P16! Let's not forget this little Gem found by our little friend from Leipzig. As GC stated - "BRILLIANT" work! I'll take his words to mean great things.
"What was most intriguing about this article for me was the author’s discussion about the availability of Alzheimer’s blood tests being described in the future tense. We believe the timing of this article is ideal, as our emerging diagnostics division, Amarantus Diagnostics, is ready to have a major impact in the field of biomarkers to diagnose Alzheimer’s disease, and potentially monitor drug response."
P.S. Let the "MAN" and his TEAM do their job. Anyone that knows anything about BUSINESS knows one thing - it has so many moving parts - some in one's control others not - that MANAGEMENT needs to constantly be "tweaking" its roadmap. Some here know how invested I am (over my head) and I have never felt as confident about Amarantus as I do currently. It is easy to be disappointed and lose patience considering we sit at .08. However, in the "blink of an eye" we will be in the dollars without a RS IMO. Have FAITH or alleviate your mind and just sell. Two words constantly resonate whenever I think of AMARANTUS - "Golden Goose!"
Manolo
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼